“Assisted Reproductive Technology Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,” the global assisted reproductive technology market was valued at $2.317 billion in 2020, and is estimated to reach $12.272 billion by 2030, growing at a CAGR of 19.3% from 2021 to 2030.
Assisted reproductive technology (ART) is defined as the technology used for treatment of infertility. It provides fertility treatment that handles both a man’s sperm and a woman’s egg. It aims to offer efficient and affordable care in order to optimize the chance of having singleton pregnancies. With the development in technology, ART has focused on the biochemical and genetic research for the delivery of healthy babies. It eradicates the burden of infertility on families and individuals. It offers real opportunities to improve medical outcomes and enhance efficiency.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/13442
Prime determinants of growth
Surge in prevalence of infertility rate, technological advancements in assisted reproductive technology, growth in disposable income, and rise in awareness regarding infertility treatment drive the growth of the global assisted reproductive technology market. However, high cost of ART procedures and risk associated with IVF treatment hinder the market growth. On the other hand, growing opportunities in emerging markets and rise in fertility tourism present new opportunities in the coming years.
Covid-19 Scenario
- The outbreak of the Covid-19 pandemic led to impact positively on the global assisted reproductive technology industry, owing to multiple strategic steps made by organizations.
- The government authorities across different countries have approved assisted reproductive technology for the treatment of infertile couples, which in turn, has offered lucrative opportunities for the growth of the market, during the pandemic period.
- Moreover, in the post COVID era, the market is anticipated to witness exponential growth, majorly due to the success rate of assisted reproductive technologies.
The Accessory and Disposable segment to maintain its leadership status throughout the forecast period
Based on product, the accessory and disposable segment held the highest market share in 2020, accounting for more than half of the global assisted reproductive technology market, and is estimated to maintain its leadership status throughout the forecast period. This is due to rise in prevalence of infertility, surge in demand for in vitro fertilization procedures such as retrieval of oocytes, analysis & screening of sperms, handling gametes, and others. However, the instrument segment is projected to manifest the highest CAGR of 23.10% from 2021 to 2030, owing to increase in demand for frozen embryo transfer, rise in prevalence of infertility, and surge in number of IVF procedures.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/13442
The fertility clinics segment to maintain its lead position during the forecast period
Based on end-user industry, the fertility clinics segment accounted for the largest share in 2020, contributing to more than half of the global assisted reproductive technology market, and is projected to maintain its lead position during the forecast period. This is due to rise in prevalence of fertility cases, the surge in sedentary lifestyle, and growth in number of fertility clinics. Moreover, this segment is expected to portray the largest CAGR of 20.5% from 2021 to 2030.
Europe, followed by North America, to maintain its dominance by 2030
Based on region, Europe, followed by North America, held the highest market share in terms of revenue 2020, accounting for nearly two-fifths of the global assisted reproductive technology market. This is due to increase in utilization of novel technology equipment service, surge in incidence of infertility cases, high disposable incomes, rise of funds from government and private organizations for in-vitro fertilization (IVF), and advancements in technology for infertility. However, the Asia-Pacific region is expected to witness the fastest CAGR of 21.3% during the forecast period, owing to increase in incidence of infertility cases, rise in awareness about surrogacy, and surge in demand for assisted reproductive technology.
Leading Market Players:-
- Cook Medical Inc.
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Genea Biomedx
- Merck KGaA (EMD Serono, Inc.)
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- The Cooper Companies, Inc. (CooperSurgical, Inc.)
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
KEY FINDINGS OF THE STUDY
- By product, the accessory & disposable segment was the highest contributor to the market in 2020.
- By technology, the in vitro fertilization segment was the highest contributor to the market in 2020.
- By end user, the fertility clinic segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
- By region, Europe garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry:
Diabetic Nephropathy Market: https://www.alliedmarketresearch.com/diabetic-nephropathy-market-A16604
Monoclonal Antibodies Market: https://www.alliedmarketresearch.com/monoclonal-antibodies-market-A11789
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com